Medivir AB today announces that data will be presented on the investigational protease inhibitor simeprevir for the treatment of hepatitis C at The International Liver Congress 2013 of the European Association for the Study of the Liver , which will take place April 24 to 28 in Amsterdam, The Netherlands.
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130408005690&newsLang=en&ndmConfigId=1000639&vnsId=41
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130408005690&newsLang=en&ndmConfigId=1000639&vnsId=41
No comments:
Post a Comment